Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.

Lee, Joohyung

Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson's disease. [electronic resource] - Synapse (New York, N.Y.) Apr 2008 - 310-3 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0887-4476

10.1002/syn.20481 doi


Adrenergic Agents--toxicity
Animals
Corpus Striatum--drug effects
Disease Models, Animal
Dopamine Agents--pharmacology
Dyskinesia, Drug-Induced--physiopathology
Gene Expression
In Situ Hybridization
Intracellular Signaling Peptides and Proteins
Levodopa--pharmacology
Membrane Proteins--biosynthesis
Motor Activity--drug effects
Oxidopamine--toxicity
Parkinsonian Disorders--drug therapy
RNA, Messenger--analysis
Rats
Rats, Sprague-Dawley
Receptor Activity-Modifying Protein 1
Receptor Activity-Modifying Proteins